Dermapharm Holding SE Bearer Shares (EUR)
DMP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range59.01 | 60.16
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINDE000A2GS5D8
Volume50,914.00
Exchange VenueETR

Company Profile

Dermapharm Holding SE is a manufacturer of patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 26/01/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.dermapharm.de

Financials

Income Statement
EUR201520162017201820192020
Revenue (m)384.84444.48467.12572.42700.88-
Operating Income (m)67.6486.1090.82108.86119.74-
Net Income (m)12.7016.8277.7475.3277.20-
Basic EPS0.240.311.441.411.43-
Avg. Diluted Shares Outstanding (m)53.8453.8453.8453.4253.84-
Balance Sheet
EUR201520162017201820192020
Current Assets (m)142.10156.96192.87371.24352.94-
Non Current Assets (m)154.56154.74222.43333.34691.93-
Total Assets (m)296.67311.70415.30704.581,044.87-
Current Liabilities (m)61.57115.4280.58146.40102.42-
Total Liabilities (m)------
Total Equity (m)41.1056.9273.69252.45278.65-
Cash Flows
EUR201520162017201820192020
Operating Cash Flows (m)40.3876.7886.74159.13100.61-
Capital Expenditure (m)-14.93-17.76-74.72-25.97-46.44-
Figures are quoted in EUR unless stated otherwise
59.28
Last Price